Ocular drug-metabolizing enzymes: focus on esterases

References

• Abet V, Filace F, Recio J, Alvarez-Builla J, Burgos C. 2017. Prodrug approach: an overview of recent cases. Eur J Med Chem. 127:810–827. doi: 10.1016/j.ejmech.2016.10.061.
   PubMed Web of Science ®Google Scholar
• Acheampong AA, Shackleton M, John B, Burke J, Wheeler L, Tang-Liu D. 2002. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. Drug Metab Dispos. 30(4):421–429. doi: 10.1124/dmd.30.4.421.
   Web of Science ®Google Scholar
• Ahmad H, Singh SV, Medh RD, Ansari GAS, Kurosky A, Awasthi YC. 1988. Differential expression of α, μ and π classes of isozymes of glutathione S-transferase in bovine lens, cornea, and retina. Arch Biochem Biophys. 266(2):416–426. doi: 10.1016/0003-9861(88)90273-1.
   Web of Science ®Google Scholar
• Ahmad H, Singh SV, Srivastava SK, Awasthi YC. 1989. Glutathione S-transferases of bovine iris and ciliary body: characterization of isoenzymes. Curr Eye Res. 8(2):175–184. doi: 10.3109/02713688908995189.
   PubMed Web of Science ®Google Scholar
• Ahmad MT, Zhang P, Dufresne C, Ferrucci L, Semba RD. 2018. The human eye proteome project: updates on an emerging proteome. Proteomics. 18(5–6):e1700394. doi: 10.1002/pmic.201700394.
   Web of Science ®Google Scholar
• Ahmed I. 2003. The noncorneal route in ocular drug delivery. Drugs Pharm Sci. 130:335–364.
   Google Scholar
• Al-Ghananeem AM, Crooks PA. 2007. Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery. Molecules. 12(3):373–388. doi: 10.3390/12030373.
   PubMed Web of Science ®Google Scholar
• Appleyard ME, McDonald B, Benjamin L. 1991. Presence of a soluble form of acetylcholinesterase in human ocular fluids. Br J Ophthalmol. 75(5):276–279. doi: 10.1136/bjo.75.5.276.
   Web of Science ®Google Scholar
• Argikar UA, Dumouchel JL, Dunne CE, Bushee AJ. 2017. Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes. Drug Metab Rev. 49(3):372–394. doi: 10.1080/03602532.2017.1322609.
   PubMed Web of Science ®Google Scholar
• Balhara A, Basit A, Argikar UA, Dumouchel JL, Singh S, Prasad B. 2021. Comparative proteomics analysis of the postmitochondrial supernatant fraction of human lens-free whole eye and liver. Drug Metab Dispos. 49(7):592–600. doi: 10.1124/dmd.120.000297.
   Web of Science ®Google Scholar
• Barot M, Bagui M, Gokulgandhi MR, Mitra AK. 2012. Prodrug strategies in ocular drug delivery. Med Chem. 8(4):753–768. doi: 10.2174/157340612801216283.
   PubMed Web of Science ®Google Scholar
• Bennett HM, Stephenson W, Rose CM, Darmanis S. 2023. Single-cell proteomics enabled by next-generation sequencing or mass spectrometry. Nat Methods. 20(3):363–374. doi: 10.1038/s41592-023-01791-5.
   PubMed Web of Science ®Google Scholar
• Bharathidevi SR, Babu KA, Jain N, Muthukumaran S, Umashankar V, Biswas J, Angayarkanni N. 2017. Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina. Indian J Med Res. 145(4):513–520.
   Google Scholar
• Bhattacharjee J, Sanyal S. 1975. Developmental changes of esterases in the retina of the mouse: histochemical study. Histochemistry. 46(1):53–60. doi: 10.1007/BF02463560.
   Google Scholar
• Bienert A, Kamińska A, Olszewski J, Gracz J, Grabowski T, Wolc A, Grześkowiak E. 2012. Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan. Pharmacol Rep. 64(2):421–427. doi: 10.1016/S1734-1140(12)70783-1.
   Web of Science ®Google Scholar
• Bodor N, ElKoussi A, Kano M, Nakamura T. 1988. Improved delivery through biological membranes. 26. Design, synthesis, and pharmacological activity of a novel chemical delivery system for beta-adrenergic blocking agents. J Med Chem. 31(1):100–106. doi: 10.1021/jm00396a015.
   PubMed Web of Science ®Google Scholar
• Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ. 2000. Role of quinones in toxicology. Chem Res Toxicol. 13(3):135–160. doi: 10.1021/tx9902082.
   PubMed Web of Science ®Google Scholar
• Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, Casson RJ, Abdoli A, Abu-Gharbieh E, Afshin A, et al. 2021. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Global Health. 9(2):e130–e143. doi: 10.1016/S2214-109X(20)30425-3.
   PubMed Web of Science ®Google Scholar
• Burgess A, Azad T, Pathak N, Amin V, Gupta SV. 2018. Transporter-targeted prodrug approach for retina and posterior segment disease. In: Patel JK, Sutariya V, Kanwar JR, Pathak YV, editors. Cham: Springer International Publishing; p. 309–316.
   Google Scholar
• Cao Y, Samy KE, Bernards DA, Desai TA. 2019. Recent advances in intraocular sustained-release drug delivery devices. Drug Discov Today. 24(8):1694–1700. doi: 10.1016/j.drudis.2019.05.031.
   PubMed Web of Science ®Google Scholar
• Chang S-C, Chien D-S, Bundgaard H, Lee VH. 1988. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol. Exp Eye Res. 46(1):59–69. doi: 10.1016/S0014-4835(88)80093-9.
   PubMed Web of Science ®Google Scholar
• Chang S-C, Lee VH. 1982. Influence of chain length on the in vitro hydrolysis of model ester prodrugs by ocular esterases. Curr Eye Res. 2(10):651–656. doi: 10.3109/02713688209019993.
   PubMed Web of Science ®Google Scholar
• Chastain JE. 2022. Ocular pharmacokinetics. In: Ohia SE, Sharif NA, editors. Handbook of basic and clinical ocular pharmacology and therapeutics. New York (NY): Academic Press, Elsevier; p. 179–219.
   Google Scholar
• Chetoni P, Crotti P, Saettone MF. 1994. Albuterol prodrugs for ocular administration: synthesis and evaluation of the physico-chemical and IOP-depressant properties of three albuterol triesters. Int J Pharm. 105(2):147–155. doi: 10.1016/0378-5173(94)90460-X.
   Google Scholar
• Chien D-S, Schoenwald RD. 1990. Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. Pharm Res. 7(5):476–483. doi: 10.1023/a:1015808514727.
   PubMed Web of Science ®Google Scholar
• Chowdhury UR, Madden BJ, Charlesworth MC, Fautsch MP. 2010. Proteome analysis of human aqueous humor. Invest Ophthalmol Vis Sci. 51(10):4921–4931. doi: 10.1167/iovs.10-5531.
   PubMed Web of Science ®Google Scholar
• Cirello AL, Dumouchel JL, Gunduz M, Dunne CE, Argikar UA. 2017. In vitro ocular metabolism and bioactivation of ketoconazole in rat, rabbit and human. Drug Metab Pharmacokinet. 32(2):121–126. doi: 10.1016/j.dmpk.2016.11.001.
   Web of Science ®Google Scholar
• Coupland SE, Penfold PL, Billson FA. 1994. Hydrolases of anterior segment tissues in the normal human, pig and rat eye: a comparative study. Graefe’s Arch Clin Exp Ophthalmol. 232(3):182–191. doi: 10.1007/BF00176789.
   Web of Science ®Google Scholar
• Dammalli M, Murthy KR, Pinto SM, Murthy KB, Nirujogi RS, Madugundu AK, Dey G, Nair B, Gowda H, Keshava Prasad TS. 2017. Toward postgenomics ophthalmology: a proteomic map of the human choroid-retinal pigment epithelium tissue. OMICS. 21(2):114–122. doi: 10.1089/omi.2016.0170.
   Web of Science ®Google Scholar
• Davies SS, Ju W-K, Neufeld AH, Abran D, Chemtob S, Roberts LJ. 2003. Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro. J Ocular Pharmacol Ther. 19(1):45–54. doi: 10.1089/108076803762718105.
   Web of Science ®Google Scholar
• Deakin SP, Bioletto S, Bochaton-Piallat M-L, James RW. 2011. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Free Radic Biol Med. 50(1):102–109. doi: 10.1016/j.freeradbiomed.2010.09.002.
   PubMed Web of Science ®Google Scholar
• Del Amo EM, Hammid A, Tausch M, Toropainen E, Sadeghi A, Valtari A, Puranen J, Reinisalo M, Ruponen M, Urtti A, et al. 2022. Ocular metabolism and distribution of drugs in the rabbit eye: quantitative assessment after intracameral and intravitreal administrations. Int J Pharm. 613:121361. doi: 10.1016/j.ijpharm.2021.121361.
   Google Scholar
• Del Amo EM, Rimpelä A-K, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D, et al. 2017. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res. 57:134–185. doi: 10.1016/j.preteyeres.2016.12.001.
   PubMed Web of Science ®Google Scholar
• Del Amo EM, Urtti A. 2015. Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data. Exp Eye Res. 137:111–124. doi: 10.1016/j.exer.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Di L. 2019. The impact of carboxylesterases in drug metabolism and pharmacokinetics. Curr Drug Metab. 20(2):91–102. doi: 10.2174/1389200219666180821094502.
   PubMed Web of Science ®Google Scholar
• Dias C, Nashed Y, Atluri H, Mitra A. 2002. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: an evaluation using ocular microdialysis and LC–MS. Curr Eye Res. 25(4):243–252. doi: 10.1076/ceyr.25.4.243.13488.
   PubMed Web of Science ®Google Scholar
• Diwan P, Jangde R, Khunte S, Bhardwaj H, Suresh PK. 2022. Ocular drug delivery system. In: Akhtar J, Badruddeen, Ahmad M, Irfan Khan M, editors. Drug development life cycle. London (UK): IntechOpen; p. 84044.
   Google Scholar
• Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN. 2005. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res. 46(6):1239–1247. doi: 10.1194/jlr.M400511-JLR200.
   PubMed Web of Science ®Google Scholar
• Druzgala P, Wu W-M, Bodor N. 1991. Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes. Curr Eye Res. 10(10):933–937. doi: 10.3109/02713689109020329.
   PubMed Web of Science ®Google Scholar
• Dumouchel JL, Chemuturi N, Milton MN, Camenisch G, Chastain J, Walles M, Sasseville V, Gunduz M, Iyer GR, Argikar UA. 2018. Models and approaches describing the metabolism, transport, and toxicity of drugs administered by the ocular route. Drug Metab Dispos. 46(11):1670–1683. doi: 10.1124/dmd.118.082974.
   PubMed Web of Science ®Google Scholar
• Duzman E, Chen C-C, Anderson J, Blumenthal M, Twizer H. 1982. Diacetyl derivative of nadolol: I. Ocular pharmacology and short-term ocular hypotensive effect in glaucomatous eyes. Arch Ophthalmol. 100(12):1916–1919. doi: 10.1001/archopht.1982.01030040896005.
   Google Scholar
• Dyrlund TF, Poulsen ET, Scavenius C, Nikolajsen CL, Thøgersen IB, Vorum H, Enghild JJ. 2012. Human cornea proteome: identification and quantitation of the proteins of the three main layers including epithelium, stroma, and endothelium. J Proteome Res. 11(8):4231–4239. doi: 10.1021/pr300358k.
   Web of Science ®Google Scholar
• Ellis PP, Littlejohn K, Deitrich RA. 1972. Enzymatic hydrolysis of pilocarpine. Invest Ophthalmol. 11(9):747–751.
   Google Scholar
• Fayyaz A, Ranta VP, Toropainen E, Vellonen KS, Ricci GD, Reinisalo M, Heikkinen EM, Gardner I, Urtti A, Jamei M, et al. 2020. Ocular intracameral pharmacokinetics for a cocktail of timolol, betaxolol, and atenolol in rabbits. Mol Pharm. 17(2):588–594. doi: 10.1021/acs.molpharmaceut.9b01024.
   Google Scholar
• Fayyaz A, Ranta V-P, Toropainen E, Vellonen K-S, Valtari A, Puranen J, Ruponen M, Gardner I, Urtti A, Jamei M, et al. 2020. Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits. Eur J Pharm Sci. 155:105553. doi: 10.1016/j.ejps.2020.105553.
   PubMed Web of Science ®Google Scholar
• Flaxel CJ, Mulholland B, Haynes B, Gregor ZJ. 2000. Intraocular penetration of tamoxifen. Ophthalmology. 107(11):2006–2009. doi: 10.1016/S0161-6420(00)00364-X.
   Web of Science ®Google Scholar
• Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, et al. 2017. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Global Health. 5(12):e1221–e1234. doi: 10.1016/S2214-109X(17)30393-5.
   PubMed Web of Science ®Google Scholar
• Franca JR, Foureaux G, Fuscaldi LL, Ribeiro TG, Rodrigues LB, Bravo R, Castilho RO, Yoshida MI, Cardoso VN, Fernandes SO, et al. 2014. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation. PLOS One. 9(4):e95461. doi: 10.1371/journal.pone.0095461.
   PubMed Web of Science ®Google Scholar
• Fukami T, Kariya M, Kurokawa T, Iida A, Nakajima M. 2015. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases. Eur J Pharm Sci. 78:47–53. doi: 10.1016/j.ejps.2015.07.006.
   PubMed Web of Science ®Google Scholar
• Fukami T, Yokoi T, Nakajima M. 2022. Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development. Annu Rev Pharmacol Toxicol. 62(1):405–425. doi: 10.1146/annurev-pharmtox-052220-105907.
   Google Scholar
• Furman M, Lazar M, Leopold IH. 1969. Cholinesterase isoenzymes in rabbit ocular tissue homogenates. Doc Ophthalmol. 26(1):185–191. doi: 10.1007/BF00943975.
   Google Scholar
• Galiacy SD, Froment C, Mouton-Barbosa E, Erraud A, Chaoui K, Desjardins L, Monsarrat B, Malecaze F, Burlet-Schiltz O. 2011. Deeper in the human cornea proteome using nanoLC-Orbitrap MS/MS: an improvement for future studies on cornea homeostasis and pathophysiology. J Proteomics. 75(1):81–92. doi: 10.1016/j.jprot.2011.09.020.
   Web of Science ®Google Scholar
• Ganea E, Harding JJ. 2006. Glutathione-related enzymes and the eye. Curr Eye Res. 31(1):1–11. doi: 10.1080/02713680500477347.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Ananthula HK, Parenky A, Mitra AK. 2010. Ocular drug delivery. AAPS J. 12(3):348–360. doi: 10.1208/s12248-010-9183-3.
   PubMed Web of Science ®Google Scholar
• Ghia M, Lotti R, Traverso C, Mattioli F, Martelli A. 1997. Penetration of oral cefuroxime axetil into the human aqueous humor. Ophthalmologica. 211(4):229–231. doi: 10.1159/000310796.
   Web of Science ®Google Scholar
• Goel R, Murthy KR, Srikanth SM, Pinto SM, Bhattacharjee M, Kelkar DS, Madugundu AK, Dey G, Mohan SS, Krishna V, et al. 2013. Characterizing the normal proteome of human ciliary body. Clin Proteomics. 10(1):9. doi: 10.1186/1559-0275-10-9.
   Google Scholar
• Hains PG, Truscott RJ. 2010. Age-dependent deamidation of lifelong proteins in the human lens. Invest Ophthalmol Vis Sci. 51(6):3107–3114. doi: 10.1167/iovs.09-4308.
   PubMed Web of Science ®Google Scholar
• Hammid A, Fallon JK, Lassila T, Salluce G, Smith PC, Tolonen A, Sauer A, Urtti A, Honkakoski P. 2021. Carboxylesterase activities and protein expression in rabbit and pig ocular tissues. Mol Pharm. 18(3):1305–1316. doi: 10.1021/acs.molpharmaceut.0c01154.
   Google Scholar
• Hammid A, Fallon JK, Lassila T, Vieiro P, Balla A, Gonzalez F, Urtti A, Smith PC, Tolonen A, Honkakoski P. 2022. Activity and expression of carboxylesterases and arylacetamide deacetylase in human ocular tissues. Drug Metab Dispos. 50(12):1483–1492. doi: 10.1124/dmd.122.000993.
   Web of Science ®Google Scholar
• Hammid A, Fallon JK, Vellonen KS, Lassila T, Reinisalo M, Urtti A, Gonzalez F, Tolonen A, Smith PC, Honkakoski P. 2023. Aldehyde oxidase 1 activity and protein expression in human, rabbit, and pig ocular tissues. Eur J Pharm Sci. 191:106603. doi: 10.1016/j.ejps.2023.106603.
   Web of Science ®Google Scholar
• Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RBG, McCarthy A, Toker L, et al. 2004. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol. 11(5):412–419. doi: 10.1038/nsmb767.
   PubMed Web of Science ®Google Scholar
• Heikkinen EM, Del Amo EM, Ranta VP, Urtti A, Vellonen KS, Ruponen M. 2018. Esterase activity in porcine and albino rabbit ocular tissues. Eur J Pharm Sci. 123:106–110. doi: 10.1016/j.ejps.2018.07.034.
   Web of Science ®Google Scholar
• Heikkinen EM, Ruponen M, Jasper L-M, Leppänen J, Hellinen L, Urtti A, Auriola S, Rautio J, Vellonen K-S. 2020. Prodrug approach for posterior eye drug delivery: synthesis of novel ganciclovir prodrugs and in vitro screening with cassette dosing. Mol Pharm. 17(6):1945–1953. doi: 10.1021/acs.molpharmaceut.0c00037.
   PubMedGoogle Scholar
• Hellberg MR, Ke T-L, Haggard K, Klimko PG, Dean TR, Graff G. 2003. The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2α by human and rabbit ocular tissue. J Ocular Pharmacol Ther. 19(2):97–103. doi: 10.1089/108076803321637627.
   PubMed Web of Science ®Google Scholar
• Hosseini K, Matsushima D, Johnson J, Widera G, Nyam K, Kim L, Xu Y, Yao Y, Cormier M. 2008. Pharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbits. J Ocular Pharmacol Ther. 24(3):301–308. doi: 10.1089/jop.2007.0117.
   Web of Science ®Google Scholar
• Huttunen KM, Rautio J. 2011. Prodrugs—an efficient way to breach delivery and targeting barriers. Curr Top Med Chem. 11(18):2265–2287. doi: 10.2174/156802611797183230.
   PubMed Web of Science ®Google Scholar
• Ichhpujani P, Katz LJ, Hollo G, Shields CL, Shields JA, Marr B, Eagle R, Alvim H, Wizov SS, Acheampong A, et al. 2012. Comparison of human ocular distribution of bimatoprost and latanoprost. J Ocular Pharmacol Ther. 28(2):134–145. doi: 10.1089/jop.2011.0097.
   PubMed Web of Science ®Google Scholar
• Imai T, Taketani M, Shii M, Hosokawa M, Chiba K. 2006. Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab Dispos. 34(10):1734–1741. doi: 10.1124/dmd.106.009381.
   PubMed Web of Science ®Google Scholar
• Järvinen T, Poikolainen M, Suhonen P, Vepsäläinen J, Alaranta S, Urtti A. 1995. Comparison of enzymatic hydrolysis of pilocarpine prodrugs in human plasma, rabbit cornea, and butyrylcholinesterase solutions. J Pharm Sci. 84(5):656–660. doi: 10.1002/jps.2600840525.
   Web of Science ®Google Scholar
• Kaluzhny Y, Kinuthia MW, Truong T, Lapointe AM, Hayden P, Klausner M. 2018. New human organotypic corneal tissue model for ophthalmic drug delivery studies. Investig Ophthalmol Vis Sci. 59(7):2880–2898.
   Web of Science ®Google Scholar
• Kawakami S, Yamamura K, Mukai T, Nishida K, Nakamura J, Sakaeda T, Nakashima M, Sasaki H. 2001. Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes. J Pharm Pharmacol. 53(8):1157–1161. doi: 10.1211/0022357011776423.
   Web of Science ®Google Scholar
• Keating GM. 2013. Intracameral cefuroxime: prophylaxis of postoperative endophthalmitis after cataract surgery. Drugs. 73(2):179–186. doi: 10.1007/s40265-013-0011-9.
   PubMed Web of Science ®Google Scholar
• Khojasteh SC, Wong H, Hop CECA. 2011. Drug metabolizing enzymes. In: Drug metabolism and pharmacokinetics quick guide. New York (NY): Springer; p. 17–46. doi: 10.1007/978-1-4419-5629-3_2.
   Google Scholar
• Kidron H, Vellonen K-S, Del Amo EM, Tissari A, Urtti A. 2010. Prediction of the corneal permeability of drug-like compounds. Pharm Res. 27(7):1398–1407. doi: 10.1007/s11095-010-0132-8.
   Web of Science ®Google Scholar
• Kishida K, Matsumoto K, Manabe R, Sugiyama T. 1986. Cytochrome P-450 and related components of the microsomal electron transport system in the bovine ciliary body. Curr Eye Res. 5(7):529–533. doi: 10.3109/02713688608996376.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Fukami T, Nakajima A, Watanabe A, Nakajima M, Yokoi T. 2012. Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse. Drug Metab Dispos. 40(4):671–679. doi: 10.1124/dmd.111.043067.
   PubMed Web of Science ®Google Scholar
• Kölln C, Reichl S. 2012. mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs. J Ocular Pharmacol Ther. 28(3):271–277. doi: 10.1089/jop.2011.0124.
   Web of Science ®Google Scholar
• Kölln C, Reichl S. 2016. Expression of glutathione transferases in corneal cell lines, corneal tissues and a human cornea construct. Int J Pharm. 506(1–2):371–381. doi: 10.1016/j.ijpharm.2016.04.053.
   Google Scholar
• Kour J, Kumari N, Sapra B. 2021. Ocular prodrugs: attributes and challenges. Asian J Pharm Sci. 16(2):175–191. doi: 10.1016/j.ajps.2020.08.002.
   Web of Science ®Google Scholar
• Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB. 2013. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy. 33(2):210–222. doi: 10.1002/phar.1194.
   PubMed Web of Science ®Google Scholar
• Laude A, Tan LE, Wilson CG, Lascaratos G, Elashry M, Aslam T, Patton N, Dhillon B. 2010. Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics. Prog Retin Eye Res. 29(6):466–475. doi: 10.1016/j.preteyeres.2010.04.003.
   PubMed Web of Science ®Google Scholar
• Lee VH, Iimoto DS, Takemoto KA. 1982. Subcellular distribution of esterases in the bovine eye. Curr Eye Res. 2(12):869–876. doi: 10.3109/02713688209020024.
   PubMed Web of Science ®Google Scholar
• Lee VH, Li VH. 1989. Prodrugs for improved ocular drug delivery. Adv Drug Deliv Rev. 3(1):1–38. doi: 10.1016/0169-409X(89)90003-3.
   Google Scholar
• Lee VH, Stratford REJr, Morimoto KW. 1983. Age-related changes in esterase activity in rabbit eyes. Int J Pharm. 13(2):183–195. doi: 10.1016/0378-5173(83)90005-4.
   Google Scholar
• Lee VH. 2019. Improved ocular drug delivery by use of chemical modification (prodrugs). In: Edman P, editor. Biopharmaceutics of ocular drug delivery. Boca Raton: CRC Press; p. 121–143.
   Google Scholar
• Lee VHI. 1983. Esterase activities in adult rabbit eyes. J Pharm Sci. 72(3):239–244. doi: 10.1002/jps.2600720310.
   PubMed Web of Science ®Google Scholar
• Lee VHL, Chang S-C, Oshiro CM, Smith RE. 1985. Ocular esterase composition in albino and pigmented rabbits: possible implications in ocular prodrug design and evaluation. Curr Eye Res. 4(11):1117–1125. doi: 10.3109/02713688509003358.
   PubMed Web of Science ®Google Scholar
• Lee VH‐L, Morimoto KW, Stratford RE. 1982. Esterase distribution in the rabbit cornea and its implications in ocular drug bioavailability. Biopharm Drug Dispos. 3(4):291–300. doi: 10.1002/bdd.2510030402.
   Web of Science ®Google Scholar
• Lehr C-M, Lee Y-H, Lee VH. 1994. Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. Investig Ophthalmol Vis Sci. 35(6):2809–2814.
   Web of Science ®Google Scholar
• Leopold IH, Furman M. 1971. Cholinesterase isoenzymes in human ocular tissue homogenates. Am J Ophthalmol. 72(2):460–463. doi: 10.1016/0002-9394(71)91320-1.
   Web of Science ®Google Scholar
• Li C, Chu S, Tan S, Yin X, Jiang Y, Dai X, Gong X, Fang X, Tian D. 2021. Towards higher sensitivity of mass spectrometry: a perspective from the mass analyzers. Front Chem. 9:813359. doi: 10.3389/fchem.2021.813359.
   PubMed Web of Science ®Google Scholar
• Lian J, Bahitham W, Panigrahi R, Nelson R, Li L, Watts R, Thiesen A, Lemieux MJ, Lehner R. 2018. Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis. Biochim Biophys Acta Mol Cell Biol Lipids. 1863(7):688–699.
   Web of Science ®Google Scholar
• Loftsson T. 2022. Topical drug delivery to the retina: obstacles and routes to success. Expert Opin Drug Deliv. 19(1):9–21. doi: 10.1080/17425247.2022.2017878.
   PubMed Web of Science ®Google Scholar
• Loukovaara S, Nurkkala H, Tamene F, Gucciardo E, Liu X, Repo P, Lehti K, Varjosalo M. 2015. Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients. J Proteome Res. 14(12):5131–5143. doi: 10.1021/acs.jproteome.5b00900.
   PubMed Web of Science ®Google Scholar
• Luo RH, Tram NK, Parekh AM, Puri R, Reilly MA, Swindle-Reilly KE. 2023. The roles of vitreous biomechanics in ocular disease, biomolecule transport, and pharmacokinetics. Curr Eye Res. 48(2):195–207. doi: 10.1080/02713683.2022.2033271.
   PubMed Web of Science ®Google Scholar
• Macha S, Duvvuri S, Mitra AK. 2004. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Curr Eye Res. 28(2):77–84. doi: 10.1076/ceyr.28.2.77.26233.
   PubMed Web of Science ®Google Scholar
• Macha S, Mitra AK. 2002. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab Dispos. 30(6):670–675. doi: 10.1124/dmd.30.6.670.
   PubMed Web of Science ®Google Scholar
• Marsillach J, Mackness B, Mackness M, Riu F, Beltrán R, Joven J, Camps J. 2008. Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol Med. 45(2):146–157. doi: 10.1016/j.freeradbiomed.2008.03.023.
   PubMed Web of Science ®Google Scholar
• Maurice DM, Mishima S. 1984. Ocular pharmacokinetics. In: Sears ML, editor. Pharmacology of the eye. Vol. 69. Berlin-Heidelberg: Springer; p. 19–116.
   Google Scholar
• Miller L, Stier M, Lovenberg W. 1980. Evidence for the presence of N-acetyl transferase in rat retina. Comp Biochem Physiol C Comp Pharmacol. 66(2):213–216. doi: 10.1016/0306-4492(80)90129-X.
   Web of Science ®Google Scholar
• Mirzaei M, Gupta VB, Chick JM, Greco TM, Wu Y, Chitranshi N, Wall RV, Hone E, Deng L, Dheer Y, et al. 2017. Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes. Sci Rep. 7(1):12685. doi: 10.1038/s41598-017-12858-7.
   PubMedGoogle Scholar
• Missel PJ. 2012. Simulating intravitreal injections in anatomically accurate models for rabbit, monkey, and human eyes. Pharm Res. 29(12):3251–3272. doi: 10.1007/s11095-012-0721-9.
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Scherer SW, Xi T, Nickle DC, Majer M, Huizenga JJ, Tsui L-C, Prochazka M. 1998. Human PON2 gene at 7q21. 3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene. 213(1–2):149–157. doi: 10.1016/s0378-1119(98)00193-0.
   PubMed Web of Science ®Google Scholar
• Morrison PWJ, Khutoryanskiy VV. 2014. Anatomy of the eye and the role of ocular mucosa in drug delivery. In: Khutoryanskiy VV, editor. Mucoadhesive materials and drug delivery systems. 1st ed.Hoboken (NJ): Wiley Online Library; p. 39–60. doi: 10.1002/9781118794203.ch02.
   Google Scholar
• Mu X, Yi X, Xiao S, Wang C, Chen G, Li Y. 2018. Substrates for paraoxonase. Curr Pharm Des. 24(5):615–627. doi: 10.2174/1381612824666171213102310.
   Web of Science ®Google Scholar
• Murthy KR, Dammalli M, Pinto SM, Murthy KB, Nirujogi RS, Madugundu AK, Dey G, Subbannayya Y, Mishra UK, Nair B, et al. 2016. A comprehensive proteomics analysis of the human iris tissue: ready to embrace postgenomics precision medicine in ophthalmology? OMICS. 20(9):510–519. doi: 10.1089/omi.2016.0100.
   Web of Science ®Google Scholar
• Nakajima A, Fukami T, Kobayashi Y, Watanabe A, Nakajima M, Yokoi T. 2011. Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine. Biochem Pharmacol. 82(11):1747–1756. doi: 10.1016/j.bcp.2011.08.003.
   PubMed Web of Science ®Google Scholar
• Navratil T, Garcia A, Verhoeven RS, Trevino L, Gilger BC, Mansberger SL, Budenz DL, Ahmed IIK, Lewis RA, Yerxa BR. 2015. Advancing ENV515 (travoprost) intracameral implant into clinical development: nonclinical evaluation of ENV515 in support of first-time-in-human phase 2a clinical study. Investig Ophthalmol Vis Sci. 56(7):5706.
   PubMedGoogle Scholar
• Niemi R, Huuskonen J, Laine K, Järvinen T. 2005. Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs. Int J Pharm. 295(1–2):121–127. doi: 10.1016/j.ijpharm.2005.02.002.
   Google Scholar
• Oh C, Saville BA, Cheng YL, Rootman DS. 1995. A compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm Res. 12:433–437.
   PubMed Web of Science ®Google Scholar
• Patane MA, Schubert W, Sanford T, Gee R, Burgos M, Isom WP, Ruiz-Perez B. 2013. Evaluation of ocular and general safety following repeated dosing of dexamethasone phosphate delivered by transscleral iontophoresis in rabbits. J Ocular Pharmacol Ther. 29(8):760–769. doi: 10.1089/jop.2012.0175.
   PubMed Web of Science ®Google Scholar
• Peynshaert K, Devoldere J, De Smedt SC, Remaut K. 2018. In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye. Adv Drug Deliv Rev. 126:44–57. doi: 10.1016/j.addr.2017.09.007.
   PubMed Web of Science ®Google Scholar
• Pikuleva IA. 2023. Challenges and opportunities in p450 research on the eye. Drug Metab Dispos. 51(10):1295–1307. doi: 10.1124/dmd.122.001072.
   Google Scholar
• Pitkänen L, Ranta V-P, Moilanen H, Urtti A. 2005. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci. 46(2):641–646. doi: 10.1167/iovs.04-1051.
   PubMed Web of Science ®Google Scholar
• Pryde DC, Dalvie D, Hu Q, Jones P, Obach RS, Tran T-D. 2010. Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem. 53(24):8441–8460. doi: 10.1021/jm100888d.
   PubMed Web of Science ®Google Scholar
• Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, Savolainen J. 2008. Prodrugs: design and clinical applications. Nat Rev Drug Discov. 7(3):255–270. doi: 10.1038/nrd2468.
   PubMed Web of Science ®Google Scholar
• Rautio J, Meanwell NA, Di L, Hageman MJ. 2018. The expanding role of prodrugs in contemporary drug design and development. Nat Rev Drug Discov. 17(8):559–587. doi: 10.1038/nrd.2018.46.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM. 2001. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol. 21(4):542–547. doi: 10.1161/01.ATV.21.4.542.
   PubMed Web of Science ®Google Scholar
• Redell MA, Yang DC, Lee VH. 1983. The role of esterase activity in the ocular disposition of dipivalyl epinephrine in rabbits. Int J Pharm. 17(2–3):299–312. doi: 10.1016/0378-5173(83)90041-8.
   Google Scholar
• Rimpelä A-K, Reinisalo M, Hellinen L, Grazhdankin E, Kidron H, Urtti A, Del Amo EM. 2018. Implications of melanin binding in ocular drug delivery. Adv Drug Deliv Rev. 126:23–43. doi: 10.1016/j.addr.2017.12.008.
   Web of Science ®Google Scholar
• Robert P-Y, Adenis J-P. 2001. Comparative review of topical ophthalmic antibacterial preparations. Drugs. 61(2):175–185. doi: 10.2165/00003495-200161020-00003.
   Web of Science ®Google Scholar
• Rodrigues GA, Lutz D, Shen J, Yuan X, Shen H, Cunningham J, Rivers HM. 2018. Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation. Pharm Res. 35(12):245. doi: 10.1007/s11095-018-2519-x.
   PubMed Web of Science ®Google Scholar
• Romanelli L, Valeri P, Morrone LA, Pimpinella G. 1991. Ocular disposition of acetaminophen and its metabolites following intravenous administration in rabbits. J Ocul Pharmacol. 7(4):339–350. doi: 10.1089/jop.1991.7.339.
   Google Scholar
• Rosenblat M, Coleman R, Reddy ST, Aviram M. 2009. Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1. J Lipid Res. 50(5):870–879. doi: 10.1194/jlr.M800550-JLR200.
   Web of Science ®Google Scholar
• Saarinen-Savolainen P, Järvinen T, Suhonen P, Urtti A. 1996. Amphiphilic properties of pilocarpine prodrugs. Int J Pharm. 133(1–2):171–178. doi: 10.1016/0378-5173(96)04438-9.
   Google Scholar
• Salmon JF. 2019. Kanski’s clinical ophthalmology e-book: a systematic approach. Oxford (UK): Elsevier Health Sciences.
   Google Scholar
• Sampat KM, Garg SJ. 2010. Complications of intravitreal injections. Curr Opin Ophthalmol. 21(3):178–183. doi: 10.1097/ICU.0b013e328338679a.
   PubMed Web of Science ®Google Scholar
• Sánchez‐Chávez G, Vidal CJ, Salceda R. 1995. Acetyl‐ and butyrylcholinesterase activities in the rat retina and retinal pigment epithelium. J Neurosci Res. 41(5):655–662. doi: 10.1002/jnr.490410512.
   Web of Science ®Google Scholar
• Sanghani SP, Sanghani PC, Schiel MA, Bosron WF. 2009. Human carboxylesterases: an update on CES1, CES2 and CES3. Protein Pept Lett. 16(10):1207–1214. doi: 10.2174/092986609789071324.
   Web of Science ®Google Scholar
• Sato Y, Miyashita A, Iwatsubo T, Usui T. 2012. Simultaneous absolute protein quantification of carboxylesterases 1 and 2 in human liver tissue fractions using liquid chromatography–tandem mass spectrometry. Drug Metab Dispos. 40(7):1389–1396. doi: 10.1124/dmd.112.045054.
   PubMed Web of Science ®Google Scholar
• Satoh T, Hosokawa M. 1998. The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol. 38(1):257–288. doi: 10.1146/annurev.pharmtox.38.1.257.
   PubMedGoogle Scholar
• Satoh T, Hosokawa M. 2006. Structure, function and regulation of carboxylesterases. Chem Biol Interact. 162(3):195–211. doi: 10.1016/j.cbi.2006.07.001.
   PubMed Web of Science ®Google Scholar
• Schmidt Laugesen C, Steffansen B, Scherfig E, La Cour M. 2005. Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs. Acta Ophthalmol Scand. 83(2):184–190. doi: 10.1111/j.1600-0420.2005.00429.x.
   Google Scholar
• Schoenwald RD, Harris RG, Turner D, Knowles W, Chien D‐S. 1987. Ophthalmic bioequivalence of steroid/antibiotic combination formulations. Biopharm Drug Dispos. 8(6):527–548. doi: 10.1002/bdd.2510080605.
   Web of Science ®Google Scholar
• Schoenwald RD, Huang H-S. 1983. Corneal penetration behavior of β-blocking agents I: physicochemical factors. J Pharm Sci. 72(11):1266–1272. doi: 10.1002/jps.2600721108.
   PubMed Web of Science ®Google Scholar
• Schwartzman ML, Masferrer J, Dunn MW, McGiff JC, Abraham NG. 1987. Cytochrome P450, drug metabolizing enzymes and arachidonic acid metabolism in bovine ocular tissues. Curr Eye Res. 6(4):623–630. doi: 10.3109/02713688709025223.
   PubMed Web of Science ®Google Scholar
• Shen YC, Wang MY, Wang CY, Tsai TC, Tsai HY, Lee HN, Wei LC. 2009. Pharmacokinetics of intracameral voriconazole injection. Antimicrob Agents Chemother. 53(5):2156–2157. doi: 10.1128/AAC.01125-08.
   Web of Science ®Google Scholar
• Sheng Y, Yang X, Pal D, Mitra AK. 2015. Prodrug approach to improve absorption of prednisolone. Int J Pharm. 487(1–2):242–249. doi: 10.1016/j.ijpharm.2015.04.029.
   PubMed Web of Science ®Google Scholar
• Shichi H, Nebert DW. 1982. Genetic differences in drug metabolism associated with ocular toxicity. Environ Health Perspect. 44:107–117. doi: 10.2307/3429483.
   PubMed Web of Science ®Google Scholar
• Shimada S, Mishima H, Kitamura S, Tatsumi K. 1987. Nicotinamide N-oxide reductase activity in bovine and rabbit eyes. Invest Ophthalmol Vis Sci. 28(7):1204–1206.
   Web of Science ®Google Scholar
• Shimada S, Mishima HK, Nikaido H, Kitamura S, Tatsumi K. 1989. Purification of aldehyde oxidase from bovine ciliary body. Curr Eye Res. 8(7):721–726. doi: 10.3109/02713688909025807.
   Web of Science ®Google Scholar
• Sjöquist B, Basu S, Byding P, Bergh K, Stjernschantz J. 1998. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit. Drug Metab Dispos. 26(8):745–754.
   Web of Science ®Google Scholar
• Skeie JM, Mahajan VB. 2014. Proteomic landscape of the human choroid–retinal pigment epithelial complex. JAMA Ophthalmol. 132(11):1271–1281. doi: 10.1001/jamaophthalmol.2014.2065.
   Web of Science ®Google Scholar
• Skeie JM, Roybal CN, Mahajan VB. 2015. Proteomic insight into the molecular function of the vitreous. PLOS One. 10(5):e0127567. doi: 10.1371/journal.pone.0127567.
   Web of Science ®Google Scholar
• Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, Abdoli AA, Abrha WA, Abualhasan A, Abu-Gharbieh EG, et al. 2021. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study. Lancet Global Health. 9(2):e144–e160. doi: 10.1016/S2214-109X(20)30489-7.
   PubMed Web of Science ®Google Scholar
• Subrizi A, Del Amo EM, Korzhikov-Vlakh V, Tennikova T, Ruponen M, Urtti A. 2019. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties. Drug Discov Today. 24(8):1446–1457. doi: 10.1016/j.drudis.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Suhonen P, Järvinen T, Rytkönen P, Peura P, Urtti A. 1991. Improved corneal pilocarpine permeability with O,O′-(1,4-xylylene) bispilocarpic acid ester double prodrugs. Pharm Res. 8(12):1539–1542. doi: 10.1023/A:1015806802973.
   Web of Science ®Google Scholar
• Sun Q, Zhu R, Foss FW, Macdonald TL. 2008. In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity. Chem Res Toxicol. 21(3):711–719. doi: 10.1021/tx7003085.
   PubMed Web of Science ®Google Scholar
• Terao M, Romão MJ, Leimkühler S, Bolis M, Fratelli M, Coelho C, Santos-Silva T, Garattini E. 2016. Structure and function of mammalian aldehyde oxidases. Arch Toxicol. 90(4):753–780. doi: 10.1007/s00204-016-1683-1.
   PubMed Web of Science ®Google Scholar
• Tirucherai GS, Dias C, Mitra AK. 2002. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design. J Ocular Pharmacol Ther. 18(6):535–548. doi: 10.1089/108076802321021081.
   PubMed Web of Science ®Google Scholar
• Tsuji A, Tamai I, Sasaki K. 1987. Hydrolysis of prednisolone succinate by esterase in rabbit ocular tissue. Ophthalmic Res. 19(6):322–329. doi: 10.1159/000265516.
   Web of Science ®Google Scholar
• Urtti A. 2006. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 58(11):1131–1135. doi: 10.1016/j.addr.2006.07.027.
   PubMed Web of Science ®Google Scholar
• Vellonen K-S, Hellinen L, Mannermaa E, Ruponen M, Urtti A, Kidron H. 2018. Expression, activity and pharmacokinetic impact of ocular transporters. Adv Drug Deliv Rev. 126:3–22. doi: 10.1016/j.addr.2017.12.009.
   PubMed Web of Science ®Google Scholar
• Wang D-D, Jin Q, Zou L-W, Hou J, Lv X, Lei W, Cheng H-L, Ge G-B, Yang L. 2016. A bioluminescent sensor for highly selective and sensitive detection of human carboxylesterase 1 in complex biological samples. Chem Commun. 52(15):3183–3186. doi: 10.1039/C5CC09874B.
   Web of Science ®Google Scholar
• Wang J, Williams ET, Bourgea J, Wong YN, Patten CJ. 2011. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2. Drug Metab Dispos. 39(8):1329–1333. doi: 10.1124/dmd.111.039628.
   Web of Science ®Google Scholar
• Wang W, Bundgaard H, Buur A, Lee VH. 1991. Corneal penetration of 5-fluorouracil and its improvement by prodrug derivatization in the albino rabbit: implication in glaucoma filtration surgery. Curr Eye Res. 10(1):87–97. doi: 10.3109/02713689109007613.
   Web of Science ®Google Scholar
• Wang Z, Han J, David LL, Schey KL. 2013. Proteomics and phosphoproteomics analysis of human lens fiber cell membranes. Invest Ophthalmol Vis Sci. 54(2):1135–1143. doi: 10.1167/iovs.12-11168.
   Web of Science ®Google Scholar
• Watanabe A, Fukami T, Nakajima M, Takamiya M, Aoki Y, Yokoi T. 2009. Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis. Drug Metab Dispos. 37(7):1513–1520. doi: 10.1124/dmd.109.026567.
   Web of Science ®Google Scholar
• Watanabe A, Fukami T, Takahashi S, Kobayashi Y, Nakagawa N, Nakajima M, Yokoi T. 2010. Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen. Drug Metab Dispos. 38(9):1532–1537. doi: 10.1124/dmd.110.033720.
   PubMed Web of Science ®Google Scholar
• Watkins JB, Wirthwein DP, Sanders RA. 1991. Comparative study of phase II biotransformation in rabbit ocular tissues. Drug Metab Dispos. 19(3):708–713.
   Web of Science ®Google Scholar
• Wei C, Anderson JA, Leopold I. 1978. Ocular absorption and metabolism of topically applied epinephrine and a dipivalyl ester of epinephrine. Investig Ophthalmol Vis Sci. 17(4):315–321.
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization. 2019. World report on vision. [updated 2019 Oct 8; accessed 2024 May 30]. https://www.who.int/publications-detail/ world-report-on-vision.
   Google Scholar
• Wolf J, Boneva S, Schlecht A, Lapp T, Auw-Haedrich C, Lagrèze W, Agostini H, Reinhard T, Schlunck G, Lange C. 2022. The human eye transcriptome atlas: a searchable comparative transcriptome database for healthy and diseased human eye tissue. Genomics. 114(2):110286. doi: 10.1016/j.ygeno.2022.110286.
   PubMed Web of Science ®Google Scholar
• Yang L, Li X, Tang H, Gao Z, Zhang K, Sun K. 2019. A unique role of carboxylesterase 3 (Ces3) in β-adrenergic signaling-stimulated thermogenesis. Diabetes. 68(6):1178–1196. doi: 10.2337/db18-1210.
   Web of Science ®Google Scholar
• Zhang P, Dufresne C, Turner R, Ferri S, Venkatraman V, Karani R, Lutty GA, Van Eyk JE, Semba RD. 2015. The proteome of human retina. Proteomics. 15(4):836–840. doi: 10.1002/pmic.201400397.
   Web of Science ®Google Scholar
• Zhang P, Kirby D, Dufresne C, Chen Y, Turner R, Ferri S, Edward DP, Van Eyk JE, Semba RD. 2016. Defining the proteome of human iris, ciliary body, retinal pigment epithelium, and choroid. Proteomics. 16(7):1146–1153. doi: 10.1002/pmic.201500188.
   Web of Science ®Google Scholar
• Zhang T, Xiang CD, Gale D, Carreiro S, Wu EY, Zhang EY. 2008. Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition. Drug Metab Dispos. 36(7):1300–1307. doi: 10.1124/dmd.108.021121.
   Web of Science ®Google Scholar
• Zimmerman TJ, Kooner K, Mordechai S, Fechtner DR. 1997. Textbook of ocular pharmacology. 3rd ed. Philadelphia (PA): Lippincott-Raven Williams & Wilkins.
   Google Scholar